Loading clinical trials...

Clinical Efficacy of Intense Pulsed Light(IPL) Procedure in Dry Eye Patient | Clinical Trials | Clareo Health

WITHDRAWNNA

Clinical Efficacy of Intense Pulsed Light(IPL) Procedure in Dry Eye Patient

Clinical Efficacy of Intense Pulsed Light(IPL) Procedure in Dry Eye Patients With Meibomian Gland Dysfunction Prior to Cataract Surgery

NCT04391907•Samsung Medical Center

View on ClinicalTrials.gov

Summary

Clinical efficacy of Intense Pulsed Light(IPL) procedure in dry eye patients with meibomian gland dysfunction prior to cataract surgery.

Detailed Description

IPL procedure is a device used for symptom relief and treatment of dry eye syndrome caused by meibomian gland dysfunction in adults, and its safety and long-term effects have been confirmed. The purpose of this study is to determine whether this procedure before cataract surgery is effective in improving the symptoms of dry eye syndrome after cataract surgery.

Eligibility

Age

21 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. A patient at the age of 21 cataract surgery
•2. A patient has the visual potential of 20/25 or better in each eye after cataract removal
•3. Dry eye patient by meibomian gland dysfunction
•4. Written informed consent to surgery and participation in the study

Exclusion Criteria

•1. Eye damage, active eye infection
•2. Uncontrolled health problem
•3. Wear contact lens within one month
•4. Allergic reactions of fluorescein sodium or ophtalmic anesthetic
•5. Eye surgery and trauma in the last six months
•6. Eye disease, structural abnormality
•7. If there is a cause of vision loss other than cataracts
•8. Under 20/25 expect vision
•9. Under the age of 20 years of age
•10. Pregnant woman and lactating woman
+1 more criteria

Locations (1)

Samsung Medical Center

Seoul, South Korea

Key Dates

Start Date

March 3, 2020

Primary Completion Date

March 2, 2021

Completion Date

March 2, 2021

Last Updated

May 13, 2022

Conditions

Dry Eye Syndromes

Interventions

IPL

PROCEDURE

Clinical Applications of Advanced Ophthalmic Imaging

NCT03135327

Multiple SclerosisDry Eye Syndromes+4 more

View study

RECRUITINGNA

Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD

NCT06220474

Dry Eye SyndromesMeibomian Gland Dysfunction

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 13, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Clinical Efficacy of Intense Pulsed Light(IPL) Procedure in Dry Eye Patient

Inclusion Criteria

Exclusion Criteria

Clinical Applications of Advanced Ophthalmic Imaging

Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD

Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients

3 Month Study of Alocross Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis

Comparison Of Blue Light Filter Feature and Blue Blocking Lenses in Digital Device Users With Dry Eye Patients

Preoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction